4-151671039-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004564.3(GATB):c.*135A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.524 in 1,021,494 control chromosomes in the GnomAD database, including 146,029 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.60 ( 29569 hom., cov: 32)
Exomes 𝑓: 0.51 ( 116460 hom. )
Consequence
GATB
NM_004564.3 3_prime_UTR
NM_004564.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.07
Genes affected
GATB (HGNC:8849): (glutamyl-tRNA amidotransferase subunit B) Enables glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity. Involved in glutaminyl-tRNAGln biosynthesis via transamidation and mitochondrial translation. Located in mitochondrion. Part of glutamyl-tRNA(Gln) amidotransferase complex. Implicated in combined oxidative phosphorylation deficiency 41. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 4-151671039-T-C is Benign according to our data. Variant chr4-151671039-T-C is described in ClinVar as [Benign]. Clinvar id is 1261015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.866 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATB | NM_004564.3 | c.*135A>G | 3_prime_UTR_variant | 13/13 | ENST00000263985.11 | NP_004555.1 | ||
GATB | NM_001363341.2 | c.*135A>G | 3_prime_UTR_variant | 12/12 | NP_001350270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATB | ENST00000263985 | c.*135A>G | 3_prime_UTR_variant | 13/13 | 1 | NM_004564.3 | ENSP00000263985.6 |
Frequencies
GnomAD3 genomes AF: 0.598 AC: 90873AN: 151966Hom.: 29519 Cov.: 32
GnomAD3 genomes
AF:
AC:
90873
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.511 AC: 444288AN: 869410Hom.: 116460 Cov.: 11 AF XY: 0.515 AC XY: 230532AN XY: 447398
GnomAD4 exome
AF:
AC:
444288
AN:
869410
Hom.:
Cov.:
11
AF XY:
AC XY:
230532
AN XY:
447398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.598 AC: 90977AN: 152084Hom.: 29569 Cov.: 32 AF XY: 0.594 AC XY: 44121AN XY: 74330
GnomAD4 genome
AF:
AC:
90977
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
44121
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1969
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at